
|Articles|February 15, 2004
Experience underlines efficacy of full-time occlusion for amblyopia
Anaheim, CA-Outcomes from experience spanning more than 30 years and involving hundreds of patients indicate that full-time occlusion is a highly safe and effective method for treating amblyopia and accomplishing the goal of obtaining equal visual acuity, said William E. Scott, MD, in the fourth annual Marshall M. Parks Lecture at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
When Mites Meet Their Match: Empowering Patients With Targeted Treatment for Demodex Blepharitis
5



























